MOFCOM's Stance On Novartis/Alcon

Law360, New York (September 9, 2010, 12:22 PM EDT) -- On Aug. 1, 2010, China's Anti-Monopoly Law (AML) turned two. The Ministry of Commerce (MOFCOM) — the agency in charge of merger control in China — celebrated the anniversary with a bang: on Aug. 13, it cleared the acquisition by life sciences company Novartis of a majority stake in rival Alcon, but only subject to conditions.

Almost 10 months have passed since the last time MOFCOM imposed conditions on a merger clearance decision. The Novartis/Alcon case is only the sixth MOFCOM decision involving remedies, but already...
To view the full article, register now.